Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy.

Diabetes research and clinical practice·2026
Same author

Cyclosporin a- versus tacrolimus-specific lesions in calcineurin inhibitor nephrotoxicity.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

A retrospective study of CKDu progression in Sri Lanka: analysis of kidney biopsies and association with risk factors.

BMC nephrology·2026
Same author

Associations between CT radiomics analyses and kidney biopsy in patients with kidney disease.

BMC nephrology·2026
Same author

Impact of sampling side of peritoneal biopsies on peritoneal thickness and histopathological diagnosis-A quantitative histological study in body donors.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

[Histology and more-modern nephropathology].

Innere Medizin (Heidelberg, Germany)·2026

Related Experiment Video

Updated: May 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Structural renal changes in obesity and diabetes.

Kerstin Amann1, Kerstin Benz

  • 1Department of Nephropathology, Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany. kerstin.amann@uk-erlangen.de

Seminars in Nephrology
|February 5, 2013
PubMed
Summary

Obesity is a growing epidemic linked to chronic kidney disease, even without diabetes or hypertension. Weight loss interventions can improve kidney function and offer prevention strategies.

More Related Videos

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Related Experiment Videos

Last Updated: May 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Epidemiology

Background:

  • Overweight and obesity are escalating global health issues, now considered epidemic diseases.
  • Obesity's rising incidence in children and adolescents poses long-term risks, potentially reducing life expectancy.
  • Kidney diseases are increasingly recognized as significant comorbidities associated with obesity.

Purpose of the Study:

  • To review the pathogenesis and morphology of renal functional and structural changes in obesity.
  • To explore the link between obesity and associated renal diseases, including diabetic nephropathy.
  • To highlight the clinical relevance of weight loss in managing obesity-related kidney conditions.

Main Methods:

  • This review synthesizes evidence from epidemiologic studies and clinical observations.
  • It examines the mechanisms linking obesity to kidney dysfunction.
  • Pathological and functional changes in the kidneys due to obesity are discussed.

Main Results:

  • Obesity is an independent risk factor for chronic kidney disease, irrespective of diabetes or hypertension.
  • Mechanisms include adipokine abnormalities, renin-angiotensin system activation, inflammation, and impaired renal hemodynamics.
  • Obesity exacerbates primary renal diseases and impairs post-transplant function, leading to microalbuminuria, proteinuria, and hyperfiltration.

Conclusions:

  • Obesity significantly contributes to the development and progression of kidney disease.
  • Weight loss through lifestyle changes or bariatric surgery can improve renal parameters like albuminuria and hyperfiltration.
  • Renal disease in obesity is amenable to prevention and management strategies focused on weight reduction.